TH68733A - Mixtures of polysaccharide derived from heparin Pharmaceutical preparations and mixtures containing them - Google Patents
Mixtures of polysaccharide derived from heparin Pharmaceutical preparations and mixtures containing themInfo
- Publication number
- TH68733A TH68733A TH301003718A TH0301003718A TH68733A TH 68733 A TH68733 A TH 68733A TH 301003718 A TH301003718 A TH 301003718A TH 0301003718 A TH0301003718 A TH 0301003718A TH 68733 A TH68733 A TH 68733A
- Authority
- TH
- Thailand
- Prior art keywords
- mixtures
- heparin
- polysaccharide derived
- mixture
- pharmaceutical preparations
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 12
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title claims abstract 4
- 150000004676 glycans Chemical class 0.000 title claims abstract 4
- 229920000669 heparin Polymers 0.000 title claims abstract 4
- 229960002897 heparin Drugs 0.000 title claims abstract 4
- 229920001282 polysaccharide Polymers 0.000 title claims abstract 4
- 239000005017 polysaccharide Substances 0.000 title claims abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 claims 2
- 150000002482 oligosaccharides Chemical class 0.000 claims 2
- 150000001720 carbohydrates Chemical group 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 230000001858 anti-Xa Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
Abstract
DC60 (25/12/46) การประดิษฐ์นี้เกี่ยวข้องกับของผสมของพอลิแซคคาไรด์ที่มาจากเฮพาริน ซึ่งมีมวลโมเลกุล เฉลี่ย 1500 ถึง 3000 ดาลตัน และอัตราส่วนต้าน -Xa/ต้าน-IIa มากกว่า 30 วิธีการเตรียม ของมัน และ สารผสมทางเภสัชกรรมซึ่งมีของผสมนั้น การประดิษฐ์นี้เกี่ยวข้องกับของผสมของพอลิแซคคาไรด์ที่มาจากเฮพาริน ซึ่งมีมวลโมเลกุล เฉลี่ย 1500 ถึง 3000 ดาลตัน และอัตราส่วนต้าน -Xa/ต้าน-IIa มากกว่า 30 วิธีการเตรียม ของมัน และ สารผสมทางเภสัชกรรมซึ่งมีของผสมนั้น DC60 (25/12/46) This invention involved a mixture of polysaccharide derived from heparin. It has an average molecular mass of 1500 to 3000 Dalton and an anti-Xa / anti-IIa ratio of more than 30. Its preparation methods and pharmaceutical mixtures containing those mixtures are The invention involved a mixture of polysaccharide derived from heparin. It has an average molecular mass of 1500 to 3000 Dalton and an anti-Xa / anti-IIa ratio of more than 30. Its preparation methods and pharmaceutical mixtures containing those mixtures are
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH68733A true TH68733A (en) | 2005-05-18 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shanmugam et al. | Heparinoid-active sulphated polysaccharides from marine algae as potential blood anticoagulant agents | |
| Nahain et al. | Heparin mimetics with anticoagulant activity | |
| Anastyuk et al. | Structural features and anticancer activity in vitro of fucoidan derivatives from brown alga Saccharina cichorioides | |
| ATE548393T1 (en) | MIXTURES OF OLIGOSACCHARIDES PRODUCED FROM HEPARIN, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| ATE246455T1 (en) | CARBOHYDRATE MIXTURE | |
| ES2269943T5 (en) | Highly branched soluble glucose polymers and their process of obtaining | |
| EA201000994A2 (en) | CHEMICALLY MODIFIED SMALL MOLECULES | |
| TW200511991A (en) | Rapamycin carbohydrate derivatives | |
| WO2005092929A8 (en) | Hyaluronic acid butyric esters with a low degree of substitution, procedure for their preparation and use | |
| EP1561760A3 (en) | Low molecular weight heparin salt with thriethanolamine | |
| HRP20230820T1 (en) | Heparan sulfate having high 3-o-sulfation rate of glucosamine residues | |
| PE20050246A1 (en) | HEPARIN-DERIVED OLIGOSACCHARD MIXTURES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TH68733A (en) | Mixtures of polysaccharide derived from heparin Pharmaceutical preparations and mixtures containing them | |
| Franz et al. | Novel pharmaceutical applications of polysaccharides | |
| TH71829A (en) | A mixture of oligosaccharides derived from Heparin Preparation of these mixtures And pharmacological mixtures containing these mixtures | |
| Doshi et al. | A review on molecular mechanisms and patents of marine-derived anti-thrombotic agents | |
| AR041555A1 (en) | MIXTURES OF POLYACARIDS DERIVED FROM HEPARINE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| JP2004210714A5 (en) | ||
| WO2004064777A3 (en) | Modified polysaccharides combination with anti-cancer drugs for enhanced treatment of cancer | |
| EP1232755A3 (en) | Anti-HIV agents | |
| WO2024059626A3 (en) | Biopolymers for ophthalmic use | |
| Palm | Pharmacodynamic and pharmacokinetic properties of heparin and low molecular weight heparin fragments. | |
| 王雅琪 et al. | The effects of characteristics of chitosan on the heparin loaded chitosan microspheres | |
| Bartle et al. | Danaparoid and the Prevention of Thromboembolism | |
| TH87612B (en) | Fungal immune-enhancing compounds |